CARET Scientific Leadership

Links

Operational Leadership

Scientific Leadership

Scientific Leadership

Chu Chen, M.S., Ph.D., D.A.B.C.C., is the Principal Investigator of the Carotene and Retinol Efficacy Trial (CARET); her expertise is in molecular epidemiology, genomics, transcriptomics, and clinical chemistry). She is the chair of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data. (webpage)

Gary Goodman, M.D., M.S., served as the Principal Investigator of CARET until 2018 and continues to serve as a co-investigator; his expertise is in medical oncology. He is a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data. (webpage)

Mark Thornquist, Ph.D., served as the Co-Principal Investigator of CARET until 2018 and continues to serve as a co-investigator; his expertise is in biostatistics. He is a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data. (webpage)

Marian Neuhouser, Ph.D., is a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data; her expertise is in nutritional epidemiology. (webpage)

Charles Kooperberg, Ph.D., is a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data; his expertise is in biostatistics and statistical genetics. (webpage)

Noel Weiss, M.D., Dr.P.H., is a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data; his expertise is in epidemiology. (webpage)

Gilbert Omenn, M.D., Ph.D., served as the Principal Investigator of CARET until 1997 and continues to serves as a member of the CARET Scientific Review Committee, which reviews proposals requesting the use of CARET specimens and data; his expertise is in genetics and proteomics.